Biomnis, Genoma, And The Center For Human Genetics And Laboratory Diagnostics Martinsried, Enter Agreements With Illumina, Inc. (ILMN) To Expand Access For Non-Invasive Prenatal Testing Across Europe
6/30/2014 11:01:26 AM
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it has entered into separate agreements with Biomnis, Genoma, and the Center for Human Genetics and Laboratory Diagnostics Martinsried, under which they will use the HiSeq 2500 and consumables from Illumina to develop and perform non-invasive prenatal testing (NIPT). Biomnis plans to make NIPT available in France, Genoma plans to perform NIPT services in Italy, and the Center for Human Genetics and Laboratory Diagnostics will offer NIPT in Germany.
Help employers find you! Check out all the jobs and post your resume.
comments powered by